Description
Product Description: IGF1 LR3 Magnus Pharma
The IGF1 LR3 Magnus Pharma is a high-quality and reliable product designed to enhance athletic performance and promote muscle growth. This peptide is a synthetic version of Insulin-like Growth Factor 1 (IGF-1), a naturally occurring hormone in the human body. It is known for its anabolic properties, making it a popular choice among athletes and bodybuilders.
Specific Details and Features:
- Brand: Magnus Pharma
- Product: IGF1 LR3
- Synthetic version of Insulin-like Growth Factor 1 (IGF-1)
- Purity: 99.9%
- Form: Lyophilized powder
- Available in 1mg vials
Benefits:
- Promotes muscle growth and hypertrophy
- Enhances recovery and reduces muscle soreness
- Increases protein synthesis and nitrogen retention
- Improves overall athletic performance
- Boosts fat burning and metabolism
- Enhances bone density and joint health
Possible Side Effects:
While IGF1 LR3 is generally well-tolerated, it is important to be aware of potential side effects, which may include:
- Hypoglycemia (low blood sugar)
- Water retention
- Joint pain
- Headaches
- Increased risk of certain cancers (if abused or used improperly)
Usage and Dosage:
For beginners, it is recommended to start with a low dosage of 20-40mcg per day, divided into two doses. Experienced athletes can gradually increase the dosage up to 100mcg per day, divided into multiple doses. It is important to follow a cycle of 4-6 weeks and then take a break to avoid desensitization.
Value for Buyers:
Purchasing IGF1 LR3 Magnus Pharma from our online sports pharmacy, anabolic-steroidsprice.com, in England offers several advantages:
- Authentic and high-quality products
- Competitive prices
- Discreet packaging and secure delivery
- Convenient online ordering process
- Responsive customer support
- Fast and reliable shipping
By choosing anabolic-steroidsprice.com, you can be confident in the quality and authenticity of the IGF1 LR3 Magnus Pharma product, ensuring optimal results and satisfaction.
Reviews
There are no reviews yet.